ERVIN GRAVES STRATEGY GROUP, LLC

Lobbying for AMERICAN MEDICINES COMPANY · Manufacturer of Generic Medication

Filing 4th Quarter - Report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 19, 2026

Income

$30,000.00

What the client paid this registrant for the period.

Client based in

Virginia

Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 1

Health Issues

Appropriations/Funding and Support for strengthening the domestic supply chain for generic medication manufacturing.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.